DDX39 acts as a suppressor of invasion for bladder cancer (Q39366011)

11 September 2017

DDX39 acts as a suppressor of invasion for bladder cancer (English)

1 reference

11 September 2017

Anna Kakehashi

4

0 references

author name string

Minoru Kato

1

1 reference

11 September 2017

Min Wei

2

1 reference

11 September 2017

Shotaro Yamano

3

1 reference

11 September 2017

Satoshi Tamada

5

1 reference

11 September 2017

Tatsuya Nakatani

6

1 reference

11 September 2017

Hideki Wanibuchi

7

1 reference

11 September 2017

4 June 2012

1 reference

11 September 2017

1 reference

11 September 2017

103

1 reference

11 September 2017

7

1 reference

11 September 2017

1363-1369

1 reference

11 September 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

Differential Plasma Glycoproteome of p19 Skin Cancer Mouse Model Using the Corra Label-Free LC-MS Proteomics Platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

Bikunin loss in urine as useful marker for bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

Bladder cancer: epidemiology, staging and grading, and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

Comparative proteomics analysis of vascular smooth muscle cells incubated with S- and R-enantiomers of atenolol using iTRAQ-coupled two-dimensional LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

Growth-regulated expression and G0-specific turnover of the mRNA that encodes URH49, a mammalian DExH/D box protein that is highly related to the mRNA export protein UAP56

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

Intracellular characterization of DDX39, a novel growth-associated RNA helicase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02298.X

Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1

21 January 2018

1 reference

12 December 2020

Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome

1 reference

12 December 2020

p53 immunohistochemistry in bladder cancer--a new approach to an old question

1 reference

12 December 2020

Over-expression of RNA helicases in cancer.

1 reference

12 December 2020

Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer

1 reference

12 December 2020

Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer

1 reference

12 December 2020

DDX39, upregulated in lung squamous cell cancer, displays RNA helicase activities and promotes cancer cell growth

1 reference

12 December 2020

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer

1 reference

12 December 2020

Natural history and treatment of low and high risk superficial bladder tumors

1 reference

12 December 2020

Multimodality therapy for the treatment of muscle-invasive bladder cancer.

1 reference

12 December 2020

Protein expression patterns of ezrin are predictors of progression in T1G3 bladder tumours treated with nonmaintenance bacillus Calmette-Guérin

1 reference

12 December 2020

Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples

1 reference

12 December 2020

Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ

1 reference

12 December 2020

10.1111/J.1349-7006.2012.02298.X

Identifiers

DOI

1 reference

11 September 2017

0 references

1 reference